Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Vitamin D Deficiency in Adolescent Girls
Vitamin D Deficiency in Adolescent Girls
Status: Enrolling
Updated:  4/18/2012
2578
mi
from 91732
Boston, MA
Vitamin D Deficiency in Adolescent Girls
Vitamin D Deficiency in Adolescent Girls
Status: Enrolling
Updated: 4/18/2012
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Pediatric Appendicitis Pathway Study
Pediatric Appendicitis Pathway Study
Status: Enrolling
Updated:  5/1/2012
826
mi
from 91732
Portland, OR
Pediatric Appendicitis Pathway Study
Pediatric Appendicitis Pathway Study
Status: Enrolling
Updated: 5/1/2012
Oregon Health and Science Univerisity
826
mi
from 91732
Portland, OR
Click here to add this to my saved trials
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
rTMS Bimodal Treatment For Patients With Subjective Idiopathic Tinnitus: A Pilot Study
Status: Enrolling
Updated:  5/1/2012
1569
mi
from 91732
Saint Louis, MO
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
rTMS Bimodal Treatment For Patients With Subjective Idiopathic Tinnitus: A Pilot Study
Status: Enrolling
Updated: 5/1/2012
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated:  5/3/2012
1195
mi
from 91732
Fort Worth, TX
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated: 5/3/2012
Alcon Call Center
1195
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Nebivolol in the Supine Hypertension of Autonomic Failure
Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity
Status: Enrolling
Updated:  5/10/2012
1763
mi
from 91732
Nashville, TN
Nebivolol in the Supine Hypertension of Autonomic Failure
Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity
Status: Enrolling
Updated: 5/10/2012
Vanderbilt University
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated:  5/15/2012
2578
mi
from 91732
Boston, MA
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated: 5/15/2012
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated:  5/15/2012
2375
mi
from 91732
Philadelphia, PA
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated: 5/15/2012
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
NSAID RCT for Prevention of Altitude Sickness
Prospective, Double-blind, Randomized, Placebo-controlled Trial of Ibuprofen Versus Placebo for Prevention of Neurologic Forms of Altitude Sickness
Status: Enrolling
Updated:  5/23/2012
296
mi
from 91732
Bridgeport, CA
NSAID RCT for Prevention of Altitude Sickness
Prospective, Double-blind, Randomized, Placebo-controlled Trial of Ibuprofen Versus Placebo for Prevention of Neurologic Forms of Altitude Sickness
Status: Enrolling
Updated: 5/23/2012
Marine Mountain Warfare Training Center
296
mi
from 91732
Bridgeport, CA
Click here to add this to my saved trials
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated:  5/31/2012
1313
mi
from 91732
Sioux Falls, SD
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated: 5/31/2012
Avera Sports Institute
1313
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Earset Healthy Volunteer Study
Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers
Status: Enrolling
Updated:  5/31/2012
329
mi
from 91732
East Palo Alto, CA
Earset Healthy Volunteer Study
Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers
Status: Enrolling
Updated: 5/31/2012
CEI Medical Group
329
mi
from 91732
East Palo Alto, CA
Click here to add this to my saved trials
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
343
mi
from 91732
Phoenix, AZ
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Arizona Ear Center
343
mi
from 91732
Phoenix, AZ
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
95
mi
from 91732
LaJolla, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
California Hearing and Balance Center
95
mi
from 91732
LaJolla, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
31
mi
from 91732
Newport Beach, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Shohet Ear Associates Medical Group
31
mi
from 91732
Newport Beach, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
313
mi
from 91732
San Jose, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Camino Ear, Nose and Throat Clinic
313
mi
from 91732
San Jose, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
340
mi
from 91732
San Mateo, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Hearing Resource Center
340
mi
from 91732
San Mateo, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
2281
mi
from 91732
Washington,
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
The George Washington University- Department of Otolaryngology
2281
mi
from 91732
Washington,
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
2320
mi
from 91732
Miami, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
University of Miami Miller School of Medicine
2320
mi
from 91732
Miami, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
2136
mi
from 91732
Tampa, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Physicians Choice Hearing and Dizziness Center
2136
mi
from 91732
Tampa, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
1966
mi
from 91732
Detroit, MI
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Henry Ford Health System- Department of Otolayrngology and Audiology
1966
mi
from 91732
Detroit, MI
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
2432
mi
from 91732
New York, NY
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
New York Otology
2432
mi
from 91732
New York, NY
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
2218
mi
from 91732
Raleigh, NC
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Carolina Ear and Hearing Clinic, PC
2218
mi
from 91732
Raleigh, NC
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
1188
mi
from 91732
San Antonio, TX
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Ear Medical Group
1188
mi
from 91732
San Antonio, TX
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
570
mi
from 91732
Salt Lake City, UT
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
University Health Science Center (University of Utah Hospital)
570
mi
from 91732
Salt Lake City, UT
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
345
mi
from 91732
Phoenix, AZ
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Southwest Autism Research and Resource Center
345
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
23
mi
from 91732
Long Beach, CA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Miller Children's Hospital Research Administration
23
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
363
mi
from 91732
Sacramento, CA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of California, Davis, M.I.N.D. Institute
363
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
825
mi
from 91732
Aurora, CO
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Colorado Denver, Children's Hospital
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2321
mi
from 91732
Miami, FL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Miami, Mailman Center for Child Development
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2179
mi
from 91732
Orange City, FL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Lake Mary Pediatrics
2179
mi
from 91732
Orange City, FL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1922
mi
from 91732
Atlanta, GA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Emory University School of Medicine
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1726
mi
from 91732
Chicago, IL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1793
mi
from 91732
Indianapolis, IN
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2302
mi
from 91732
Baltimore, MD
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Kennedy Krieger Institute
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2540
mi
from 91732
Worcester, MA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Massachusetts
2540
mi
from 91732
Worcester, MA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1472
mi
from 91732
Columbia, MO
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Missouri, Thompson Research Center for Autism & Neurodevelpmental Disorders
1472
mi
from 91732
Columbia, MO
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2435
mi
from 91732
New York, NY
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Seaver Autism Center, Mount Sinai Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2426
mi
from 91732
Staten Island, NY
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
New York State Institute for Basic Research in Developmental Disabilities
2426
mi
from 91732
Staten Island, NY
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2202
mi
from 91732
Durham, NC
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Duke University Clinical Research Unit
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2040
mi
from 91732
Akron, OH
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Akron Children's Hospital
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1167
mi
from 91732
Oklahoma City, OK
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Oklahoma, Physician's Child Study Center
1167
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
2363
mi
from 91732
Media, PA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Suburban Research Associates/Elwyn Genetics
2363
mi
from 91732
Media, PA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1762
mi
from 91732
Nashville, TN
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Vanderbilt Kennedy Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1347
mi
from 91732
Houston, TX
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Red Oaks Psychiatry Associates, P.A.
1347
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
1182
mi
from 91732
San Antonio, TX
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Road Runner Research
1182
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
964
mi
from 91732
Seattle, WA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay
Acquisition of Saliva Samples for Validation as a Specimen Type in the Esoterix Genetic Laboratories Fragile X Assay
Status: Enrolling
Updated:  6/7/2012
2550
mi
from 91732
Westborough, MA
Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay
Acquisition of Saliva Samples for Validation as a Specimen Type in the Esoterix Genetic Laboratories Fragile X Assay
Status: Enrolling
Updated: 6/7/2012
Integrated Genetics
2550
mi
from 91732
Westborough, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
A Randomized, Double-blind, Placebo-controlled, Study of Safety and Efficacy of Dutasteride in Combination With Tolterodine ER or Placebo in Men With Lower Urinary Tract Symptoms (LUTS) Including Urgency and Frequency
Status: Enrolling
Updated:  6/8/2012
1724
mi
from 91732
Newburgh, IN
Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
A Randomized, Double-blind, Placebo-controlled, Study of Safety and Efficacy of Dutasteride in Combination With Tolterodine ER or Placebo in Men With Lower Urinary Tract Symptoms (LUTS) Including Urgency and Frequency
Status: Enrolling
Updated: 6/8/2012
Deaconess Clinic Gateway Health Center
1724
mi
from 91732
Newburgh, IN
Click here to add this to my saved trials
Cochlear Implant PDA Based Research Platform
Multi Center Clinical Study to Assess the Safety of the UTD Cochlear Implant PDA (ciPDA) REsearch Platform
Status: Enrolling
Updated:  6/12/2012
1226
mi
from 91732
Richardson, TX
Cochlear Implant PDA Based Research Platform
Multi Center Clinical Study to Assess the Safety of the UTD Cochlear Implant PDA (ciPDA) REsearch Platform
Status: Enrolling
Updated: 6/12/2012
University of Texas - Dallas
1226
mi
from 91732
Richardson, TX
Click here to add this to my saved trials
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated:  6/22/2012
2450
mi
from 91732
Cross River, NY
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated: 6/22/2012
John Jay High School
2450
mi
from 91732
Cross River, NY
Click here to add this to my saved trials
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Status: Enrolling
Updated:  6/27/2012
2578
mi
from 91732
Boston, MA
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Status: Enrolling
Updated: 6/27/2012
Brigham and Women's Hospital Jen Center for Primary Care
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials